{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:58:32Z","timestamp":1777877912920,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["NASN School Nurse"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>The Advisory Committee on Immunization Practices recommends that the Tdap, HPV, and meningitis vaccines be administered to youth beginning between the ages of 11 and 12. The school nurse, knowledgeable about vaccine schedules and the rationale for the schedules, is in a unique position to advocate for all adolescent vaccines and their timely administration through addressing parent-guardian concerns and supporting other healthcare providers in completing the adolescent vaccines. This article reviews current recommendations for adolescent vaccinations and the actions needed to improve vaccination rates with a focus on Human Papillomavirus vaccine, the vaccine with the lowest completion rates among this age group. Additionally, school nurses are introduced to Middle School Health Starts Here, a program for school nurses designed to address the whole child as students progress from 5th grade to middle school. Public policy issues including school mandates, along with possible barriers to vaccine completion in adolescents, are discussed.<\/jats:p>","DOI":"10.1177\/1942602x17709319","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T13:00:41Z","timestamp":1496149241000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Adolescent Vaccines: Latest Recommendations, Addressing Barriers, and Improving Vaccine Rates"],"prefix":"10.1177","volume":"32","author":[{"given":"Kathleen C.","family":"Rose","sequence":"first","affiliation":[{"name":"Consulting School Nurse, National Association of School Nurses"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"bibr1-1942602X17709319","unstructured":"American Academy of Pediatrics. (2017). American Academy of Pediatrics emphasizes safety and importance of vaccines. Retrieved from https:\/\/www.aap.org\/en-us\/about-the-aap\/aap-press-room\/Pages\/American-Academy-of-Pediatrics-Emphasizes-Safety-and-Importance-of-Vaccines.aspx"},{"key":"bibr2-1942602X17709319","unstructured":"American Cancer Society. (2016). Middle school health starts here. HPV Roundtable. Retrieved from http:\/\/www.middleschoolhealth.org"},{"issue":"3","key":"bibr3-1942602X17709319","first-page":"1","volume":"139","author":"Bernstein H. H.","year":"2017","journal-title":"Pediatrics"},{"key":"bibr4-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2012). If you choose not to immunize. Retrieved from https:\/\/www.cdc.gov\/vaccines\/hcp\/conversations\/downloads\/not-vacc-risks-color-office.pdf"},{"key":"bibr5-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2014). Epidemiology of serogroup B meningococcal disease. Advisory Committee on Immunization Practices. October 30, 2014. Retrieved from www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-2014-10.pdf"},{"key":"bibr6-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2015). Vaccine information statements Tdap. Retrieved from https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/tdap.pdf"},{"key":"bibr7-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2016a). Vaccines and immunizations glossary. Retrieved from https:\/\/www.cdc.gov\/vaccines\/terms\/glossary.html"},{"key":"bibr8-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2016b). Vaccine information statements HPV. Retrieved from https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/hpv.pdf"},{"key":"bibr9-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2016c). Tdap pregnant women. Retrieved from https:\/\/www.cdc.gov\/vaccines\/pregnancy\/hcp\/guidelines.html#tdap"},{"key":"bibr10-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2016d). Vaccine information statements Men A C W Y. Retrieved from https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/mening.pdf"},{"key":"bibr11-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2016e). Vaccine information statements Men B. Retrieved from https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/mening-serogroup.html"},{"key":"bibr12-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2017a). For healthcare providers\/clinicians: you are the key. Retrieved from https:\/\/www.cdc.gov\/vaccines\/who\/teens\/for-hcp.html"},{"key":"bibr13-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2017b). Immunization schedule. Retrieved from https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/teen\/parent-version-schedule-7-18yrs.pdf"},{"key":"bibr14-1942602X17709319","unstructured":"Centers for Disease Control and Prevention. (2017c). Making the vaccine decision. Retrieved from https:\/\/www.cdc.gov\/vaccines\/parents\/vaccine-decision\/index.html?s_cid=bb-vaccines-Child-HP04-NCIRD"},{"key":"bibr15-1942602X17709319","doi-asserted-by":"publisher","DOI":"10.1177\/1942602X12452443"},{"key":"bibr16-1942602X17709319","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2384"},{"key":"bibr17-1942602X17709319","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199611000-00009"},{"key":"bibr18-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Luckett R., Feldman S. (2015). Impact of 2-4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer. Human Vaccines & Immunotherapeutics, 12(6), 1332-1342. http:\/\/dx.doi.org\/10.1080\/21645515.2015.1108500","DOI":"10.1080\/21645515.2015.1108500"},{"key":"bibr19-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Meites E., Kempe A., Markowitz L. E. (2016). Use of a 2-dose schedule for human papillomavirus vaccination\u2014updated recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report, 65, 1405-1408. http:\/\/dx.doi.org\/10.15585\/mmwr.mm6549a5","DOI":"10.15585\/mmwr.mm6549a5"},{"key":"bibr20-1942602X17709319","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1414"},{"key":"bibr21-1942602X17709319","unstructured":"NASN. (2015). Immunizations (position statement). Retrieved from https:\/\/schoolnursenet.nasn.org\/blogs\/nasn-profile\/2017\/03\/13\/immunizations-ps"},{"key":"bibr22-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Opel D. J., Heritage J., Taylor J. A., Mangione-Smith R., Salas H. S., Devere V. Robinson J. D. (2013). The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics, 132(6), 1037-1046. PMID:24190677. http:\/\/dx.doi.org\/10.1542\/peds.2013-2037","DOI":"10.1542\/peds.2013-2037"},{"key":"bibr23-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Palfrey S. (2016). New initiatives to improve HPV vaccination rates. Human Vaccines & Immunotherapeutics, 12(6), 1594-1598. http:\/\/dx.doi.org\/10.1080\/21645515.2016.1145316","DOI":"10.1080\/21645515.2016.1145316"},{"key":"bibr24-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Perkins R. B. (2016). HPV vaccinations: clinical potential, implementation challenges, and future directions. Human Vaccines & Immunotherapeutics, 12(6), 1327-1331. http:\/\/dx.doi.org\/10.1080\/21645515.2016.1177680.","DOI":"10.1080\/21645515.2016.1177680"},{"key":"bibr25-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Perkins R. B. (2015). Why don\u2019t adolescents finish the HPV vaccine series? A qualitative study of parents and providers. Human Vaccines & Immunotherapeutics, 12(6), 1528-1535. http:\/\/dx.doi.org\/10.1080\/21645515.2015.1118594","DOI":"10.1080\/21645515.2015.1118594"},{"key":"bibr26-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Perkins R. B., Clark J. A. (2013). Providers\u2019 perceptions of parental concerns about HPV vaccination. Journal of Health Care for Poor and Underserved, 24, 828-839. PMID:23728048. http:\/\/dx.doi.org\/10.1353\/hpu.2013.0080","DOI":"10.1353\/hpu.2013.0080"},{"key":"bibr27-1942602X17709319","doi-asserted-by":"crossref","unstructured":"Reagan-Steiner S., Yankey D., Jeyarajah J. (2015). National, regional, state and selected local area vaccination coverage among adolescents aged 13-17 years, United States, 2014. MMWR Morb Mortal Wkly Rep 64: 784\u2013792. https:\/\/stacks.cdc.gov\/view\/cdc\/32465","DOI":"10.15585\/mmwr.mm6429a3"},{"key":"bibr28-1942602X17709319","doi-asserted-by":"publisher","DOI":"10.1177\/1059840516665216"}],"container-title":["NASN School Nurse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1942602X17709319","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1942602X17709319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:05:50Z","timestamp":1777590350000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1942602X17709319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1177\/1942602X17709319"],"URL":"https:\/\/doi.org\/10.1177\/1942602x17709319","relation":{},"ISSN":["1942-602X","1942-6038"],"issn-type":[{"value":"1942-602X","type":"print"},{"value":"1942-6038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]}}}